
### [NCIT:C6287](http://purl.obolibrary.org/obo/NCIT_C6287)
**Label:** Endometrial Endometrioid Adenocarcinoma

**Subclasses:** [NCIT:C40146](http://purl.obolibrary.org/obo/NCIT_C40146) (Grade 1 Endometrial Endometrioid Adenocarcinoma), [NCIT:C6290](http://purl.obolibrary.org/obo/NCIT_C6290) (Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation), [NCIT:C40147](http://purl.obolibrary.org/obo/NCIT_C40147) (Grade 2 Endometrial Endometrioid Adenocarcinoma), [NCIT:C27850](http://purl.obolibrary.org/obo/NCIT_C27850) (Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells), [NCIT:C27839](http://purl.obolibrary.org/obo/NCIT_C27839) (Endometrial Endometrioid Adenocarcinoma, Secretory Variant), [NCIT:C27849](http://purl.obolibrary.org/obo/NCIT_C27849) (Oxyphilic Endometrial Endometrioid Adenocarcinoma), [NCIT:C27846](http://purl.obolibrary.org/obo/NCIT_C27846) (Villoglandular Endometrial Endometrioid Adenocarcinoma), [NCIT:C27844](http://purl.obolibrary.org/obo/NCIT_C27844) (Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component), [NCIT:C27845](http://purl.obolibrary.org/obo/NCIT_C27845) (Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component), [NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma), [NCIT:C27843](http://purl.obolibrary.org/obo/NCIT_C27843) (Endometrial Endometrioid Adenocarcinoma with Clear Cell Change), 

**Class expressions from DL-Learner:**

- [NCIT:C60313](http://purl.obolibrary.org/obo/NCIT_C60313) (Secretory Adenocarcinoma Cell) 56.25%
- [NCIT:C36698](http://purl.obolibrary.org/obo/NCIT_C36698) (MLH1 Gene Inactivation) 56.25%
- [NCIT:C36697](http://purl.obolibrary.org/obo/NCIT_C36697) (MSH2 Gene Inactivation) 56.25%
- [NCIT:C36692](http://purl.obolibrary.org/obo/NCIT_C36692) (PTEN Gene Inactivation) 56.25%
- [NCIT:C36665](http://purl.obolibrary.org/obo/NCIT_C36665) (KRAS Gene Amplification) 56.25%
- [NCIT:C36659](http://purl.obolibrary.org/obo/NCIT_C36659) (CTNNB1 Gene Mutation) 56.25%
- [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) and [NCIT:C36943](http://purl.obolibrary.org/obo/NCIT_C36943) (Neoplastic Acinar Cell) 56.25%
- [NCIT:C36794](http://purl.obolibrary.org/obo/NCIT_C36794) (Dysplastic Glandular Cell) and [NCIT:C36943](http://purl.obolibrary.org/obo/NCIT_C36943) (Neoplastic Acinar Cell) 56.25%
- [NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell) and [NCIT:C36943](http://purl.obolibrary.org/obo/NCIT_C36943) (Neoplastic Acinar Cell) 56.25%
- [NCIT:C36773](http://purl.obolibrary.org/obo/NCIT_C36773) (Adenocarcinoma Cell) and [NCIT:C36943](http://purl.obolibrary.org/obo/NCIT_C36943) (Neoplastic Acinar Cell) 56.25%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C36943](http://purl.obolibrary.org/obo/NCIT_C36943) (Neoplastic Acinar Cell) 56.25%
- [NCIT:C60313](http://purl.obolibrary.org/obo/NCIT_C60313) (Secretory Adenocarcinoma Cell) and (not ([UBERON:4200230](http://purl.obolibrary.org/obo/UBERON_4200230) (surface of bone@en))) 56.25%
- [NCIT:C60313](http://purl.obolibrary.org/obo/NCIT_C60313) (Secretory Adenocarcinoma Cell) and (not ([UBERON:4200172](http://purl.obolibrary.org/obo/UBERON_4200172) (neck of humerus))) 56.25%
- [NCIT:C60313](http://purl.obolibrary.org/obo/NCIT_C60313) (Secretory Adenocarcinoma Cell) and (not ([UBERON:4000115](http://purl.obolibrary.org/obo/UBERON_4000115) (mineralized bone tissue))) 56.25%
- [NCIT:C60313](http://purl.obolibrary.org/obo/NCIT_C60313) (Secretory Adenocarcinoma Cell) and (not ([UBERON:4000020](http://purl.obolibrary.org/obo/UBERON_4000020) (mineralized extracellular matrix))) 56.25%


